The Use of Scan Pet for Lung Cancer

Daniela Vazquez Capdepon*

DOI: 10.26717/BJSTR.2017.01.000124

Received: June 06, 2017   Published: June 09, 2017

To view the Full Article   Peer-reviewed Article PDF

Abstract

Lung cancer is the most common cause of cancer death in Western countries, and non-small cell lung cancer (NSCLC) accounts for 80% of these neoplasms. Despite the efforts in the early diagnosis and advances in the treatment of these patients, overall survival remains very low, approximately 18% at 5 years2. The relatively low (30-50%) survival of patients with limited, potentially curable disease probably reflects the inability to detect advanced disease at initial staging

Opinion | Conclusion | Figures |